Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

3054 results about "Mesenchymal stem cell" patented technology

Mesenchymal stem cells are multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes (muscle cells) and adipocytes (fat cells which give rise to marrow adipose tissue).

Serum-free medium mesenchymal stem cell inoculation device

A serum-free medium mesenchymal stem cell inoculation device, comprising a base, a rotating assembly, a center rod, a supporting rod, a clamping assembly, a test tube, a connecting tube, an arc-shaped air chamber, a fixing rack, a cooling tube and a collecting assembly, wherein the center rod is arranged at the top of the base through the rotating assembly, the supporting rod is annularly equally spaced on an outer wall of the top of the center rod along an axis of the center rod, the test tube is arranged at an end of the supporting rod away from the center rod through the clamping assembly, the connecting tube is arranged on the test tube, the fixing rack is arranged on an outer wall of the bottom of the center rod, the arc-shaped air chamber is in communication with the connecting tube through the cooling tube, and the collecting assembly is arranged on a side of the base. According to the inoculation device, by means of mutual cooperation of the rotating assembly, a moving assembly, the clamping assembly and the collecting assembly, operation errors caused by confusion of diluted test tubes and undiluted test tubes in a liquid adding and pipetting process of a worker are avoided, thereby improving the working efficiency of the worker.
Owner:NANJING DRUM TOWER HOSPITAL

Exosome-containing eye drops as well as preparation method and application thereof

The invention relates to eye drops containing exosomes and a preparation method and application thereof, and belongs to the technical field of eye drop preparation, the eye drops comprise exosome freeze-dried powder, the exosome freeze-dried powder is prepared from the exosomes obtained after mesenchymal stem cells are treated with TNF-alpha and IFN-alpha, and a herba houttuyniae extract, the eye drops provided by the invention can inhibit the phenotype of macrophage M1 and promote the M1 to be converted into the phenotype of M2; human corneal cell proliferation, migration and damage repair are promoted; mouse cornea injury repair is accelerated; the eye drops can be used for treating xerophthalmia, conjunctivitis and keratitis, and can also be used for preventing eye diseases and relieving asthenopia; the eye drops disclosed by the invention contain the exosome obtained after the mesenchymal stem cells are treated by the TNF-alpha and the IFN-alpha, so that the anti-inflammatory ability is stronger; the mesenchymal stem cell exosome and the herba houttuyniae extract are stored in a freeze-dried form, so that the activity is stable, and the storage time is long; in addition, the cordate houttuynia is cooperated with the exosome, so that the effect playing time can be prolonged, and the use frequency is reduced.
Owner:MIWAIMI (ZHANGJIAGANG) BIOTECHNOLOGY CO LTD +1

Adipose-derived stem cell composition for wound repair as well as preparation method and application of adipose-derived stem cell composition

The invention provides an adipose-derived stem cell composition for wound repair as well as a preparation method and application thereof, and belongs to the technical field of stem cells. The method comprises the following steps: adding fetal calf serum, dexamethasone, penicillin, streptomycin, collagen, magnetic particles and a P substance into a DMEM culture medium to prepare a culture medium, performing low-frequency magnetic field culture and separation on adipose-derived stem cells to obtain a stem cell solution, performing embedding to obtain stem cell microspheres, freeze-drying supernate to obtain a paracrine culture substance, and performing freeze-drying on the paracrine culture substance to obtain the adipose-derived stem cells. The adipose-derived stem cell composition for wound repair is prepared by mixing the adipose-derived stem cell with stem cell microspheres, hydroxypropyl methyl cellulose, carboxymethyl chitosan, hyaluronic acid, glycerol and stem cell microspheres, has better effects of implanting into damaged tissues, releasing nutrient substances, promoting neovascularization, regulating oxidative stress and inducing anti-inflammatory response, is beneficial to wound repair, and has a good application prospect. The gel can be converted into a gel phase at the skin epidermis temperature of 35-37 DEG C, components are stabilized, and sustained and controlled release is realized.
Owner:BEIJING SINOMENIUM STEM CELL TECH RES INST CO LTD

Atomizing agent containing stem cell exosome as well as preparation method and application of atomizing agent

The invention provides an atomizing agent containing stem cell exosomes as well as a preparation method and application of the atomizing agent, and belongs to the technical field of exosomes. Ferroferric oxide magnetic particles are prepared, the surfaces of the ferroferric oxide magnetic particles are modified through tannic acid, berberine and adriamycin are loaded, then the ferroferric oxide magnetic particles and the exosome secreted by adipose-derived mesenchymal stem cells are mixed, incubated and centrifuged, the mixture is added into normal saline, uniform ultrasonic dispersion is conducted, and the atomizing agent containing the stem cell exosome is prepared. The prepared atomizing agent containing the stem cell exosome is simple in preparation method and wide in raw material source, the prepared atomizing agent directly enters the lung through spray administration, the unique performance of magnetic targeting drug delivery is achieved, drugs are released in a targeted and fixed-point mode, the drug effect is improved, and the effects of efficiently promoting tumor cell apoptosis and resisting lung cancer and pneumonia are achieved.
Owner:BEIJING SINOMENIUM STEM CELL TECH RES INST CO LTD

Methods for culturing mesenchymal stem cells, compositions and implementations thereof

There is provided herein methods generating a population of primed mesenchymal stem cell-derived exosomes. A method in accordance with the disclosure may comprise expanding a population of mesenchymal stem cells (MSCs) in culture, administering one or more priming agents in the culture to prime the population of MSCs and obtain a population of primed MSCs: growing the population of die primed MCSs in culture to produce a primed-MSC-derived conditioned medium; collecting the primed MSC-conditioned medium; and purifying a population of exosomes from the primed MSC-conditioned medium. The one or more priming p agents may comprise a conditioned media derived from a population of stem cells different from the population of MSCs, a Nrf2 activator, or a combination thereof. There is also provided herein methods of treating tissues such as cornea and liver using the population of exosomes from the primed MSC-conditioned medium.
Owner:PANDORUM TECH PTE LTD

Carboxymethyl chitosan-hyaluronic acid-stem cell exosome eye drops as well as preparation method and application thereof

The invention discloses carboxymethyl chitosan-hyaluronic acid-stem cell exosome eye drops as well as a preparation method and application thereof, and relates to the technical field of eye drops and medical biogel. The carboxymethyl chitosan-hyaluronic acid-stem cell exosome eye drops are prepared from tannic acid modified carboxymethyl chitosan and adipose tissue-derived stromal cell exosome freeze-dried powder, the carboxymethyl chitosan-hyaluronic acid-stem cell exosome eye drops provided by the invention can effectively treat xerophthalmia, and are stable in components, safe and reliable. The three components including the tannic acid modified carboxymethyl chitosan, the hyaluronic acid and the adipose tissue-derived stromal cell exosome coexist, so that the functions of all the components can be fully played, a synergistic effect is achieved, and a better treatment effect on xerophthalmia is achieved.
Owner:BIOLOGY INST OF SHANDONG ACAD OF SCI

Stem cell exosome anti-hair loss and hair growth compound and preparation method thereof

The invention relates to the technical field of biology, and discloses a stem cell exosome anti-hair loss and hair growth complex and a preparation method thereof.A hair growth agent is wrapped and loaded in adipose-derived mesenchymal stem cell exosome to form a drug-loaded stem cell exosome; the medicine-carrying stem cell exosome is loaded in cross-linked hydrogel composed of a gentisic acid-cyclodextrin complex and epsilon-polylysine modified hyaluronic acid to form the stem cell exosome anti-hair loss and hair growth complex, and the stem cell exosome anti-hair loss and hair growth complex is directly smeared and externally applied to the scalp surface and acts on the hair follicle infection part in a targeted mode, so that the hair loss prevention and hair growth promotion effect is achieved. The stem cell exosome anti-hair-loss and hair-growth-promoting compound can inhibit bacterial growth, relieve and treat hair follicle inflammation caused by bacterial infection and improve the scalp environment, so that under the condition that inflammation is effectively controlled, the drug-loaded stem cell exosome in the stem cell exosome anti-hair-loss and hair-growth-promoting compound is stably released, damaged hair follicle cells are repaired, hair regeneration is promoted, the exosome treatment effect is prolonged, and the anti-hair-loss and hair-growth-promoting effect is achieved. The purpose of treating alopecia is achieved.
Owner:BEIJING BOSHIYUAN HAIR RES CENT

Conductive hydrogel loaded with adipose-derived mesenchymal stem cells as well as preparation method and application of conductive hydrogel

The invention belongs to the technical field of biomedical materials, and particularly relates to adipose-derived mesenchymal stem cell loaded conductive hydrogel and a preparation method and application thereof, the preparation method comprises the following steps: step S1, after hyaluronic acid is subjected to oxidation treatment, dopamine is grafted to oxidized hyaluronic acid, and oxidized hyaluronic acid-dopamine is obtained; step S2, carrying out amination treatment on gelatin to obtain aminated gelatin; s3, mixing the oxidized hyaluronic acid-dopamine with the aminated gelatin, and carrying out Schiff base crosslinking, so as to obtain hydrogel; and step S4, loading the adipose tissue-derived stromal cells by using the hydrogel. Dopamine is grafted on an oxidized hyaluronic acid macromolecular chain through amidation reaction, the hydrophilicity and the electrical property of the macromolecular chain are improved, a catechol structure is provided to provide possibility for iron ion coordination, the tissue adhesion, the injectability, the mechanical property and the electrical conductivity of the hydrogel are improved, and the hydrogel can be applied to the field of biomedical materials. After being applied to a spinal cord injury rat model, the functional recovery can be promoted.
Owner:BINZHOU MEDICAL COLLEGE

Exosome, mesenchymal stem cell and application of exosome and mesenchymal stem cell in treatment of type 2 diabetes mellitus

The invention provides an exosome, a mesenchymal stem cell and application of the exosome and the mesenchymal stem cell in treatment of type 2 diabetes mellitus, and belongs to the technical field of biological medicine. The exosome secreted by the umbilical cord mesenchymal stem cells of the composite pretreatment group is used for treating the type 2 diabetes mellitus, and the obvious advantages are shown. Compared with a model control group, the exosome has the advantages that the glucose tolerance of diabetic rats treated by the exosome is obviously improved, the blood glucose value is reduced by about 47.5% within 120 minutes, the area under a blood glucose curve (AUC) is reduced by about 50.5%, the serum insulin is increased by about 147.7%, insulin secretion is effectively promoted, the glycosylated hemoglobin level is obviously reduced, and the long-term blood glucose control effect is good. By integrating various indexes, the exosome obtained by the composite pretreatment scheme provided by the invention has a remarkable effect of improving the illness state of rats with type 2 diabetes mellitus, provides a new effective strategy for treatment of type 2 diabetes mellitus, and shows a good application prospect.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV +1

Umbilical cord mesenchymal stem cell for treating myocardial infarction as well as preparation method and application of umbilical cord mesenchymal stem cell

ActiveCN119019494AImprove the effectiveness of treating myocardial infarctionextended dwell timeUnknown materialsPharmaceutical non-active ingredientsUmbilical cordTransmembrane protein
The invention belongs to the technical field of biological medicines, and particularly relates to umbilical cord mesenchymal stem cells as well as a preparation method and application thereof in treating myocardial infarction. The invention provides an umbilical cord mesenchymal stem cell, the umbilical cord mesenchymal stem cell secretes a specific exosome, the exosome comprises a fusion protein, and the fusion protein is formed by fusing a peptide targeting ischemic myocardial tissue and an exosome transmembrane protein CD9 and anchored on the surface of the exosome. Therefore, the exosome secreted by the umbilical cord mesenchymal stem cells has higher targeting property and activity. The invention also provides a preparation method of the umbilical cord mesenchymal stem cells, and further, the umbilical cord mesenchymal stem cells prepared by the invention are used for preparing medicines which are applied to treatment of myocardial infarction.
Owner:广州飞来爱生命科技有限公司

Stem cell exosome composition for treating erectile dysfunction and application thereof

The invention provides a stem cell exosome composition for treating erectile dysfunction and application thereof, the stem cell exosome composition comprises stem cell exosome and vasoactive intestinal peptide, and the amino acid sequence of the vasoactive intestinal peptide is shown as SEQ ID NO: 2. The amino acid structure of the vasoactive intestinal peptide is modified, so that the biological stability can be improved; the vasoactive intestinal peptide is combined with the adipose-derived mesenchymal stem cell exosome for use, so that the ED symptom can be relieved; the vasoactive intestinal peptide and the adipose tissue-derived stem cell exosome are combined for use, so that the expression level of cell factors can be adjusted, and the microenvironment of penis tissues can be improved.
Owner:SANYA PRIVATE HEALTH HOSPITAL CO LTD

Polypeptide for promoting proliferation of human umbilical cord mesenchymal stem cells and application of polypeptide in in-vitro culture of human umbilical cord mesenchymal stem cells

The invention discloses a polypeptide for promoting proliferation of human umbilical cord mesenchymal stem cells and application of the polypeptide in in-vitro culture of the human umbilical cord mesenchymal stem cells. The mesenchymal stem cells have all characteristics of stem cells, have self-renewal and multidirectional differentiation potentials, and can be differentiated into various mesenchymal tissues, such as bones, cartilages, fat and the like. How to rapidly proliferate the human umbilical cord mesenchymal stem cells in vitro so as to rapidly obtain enough seed cells in a short time has important significance. The invention provides a polypeptide with a sequence as shown in Sequence NO.1. The polypeptide has an obvious effect of promoting in-vitro proliferation of human umbilical cord mesenchymal stem cells, does not change phenotypes of the human umbilical cord mesenchymal stem cells, and can be used for in-vitro efficient amplification of the human umbilical cord mesenchymal stem cells.
Owner:JIANGSU QICHUANG CELL GENE ENGINEERING RESEARCH INSTITUTE CO LTD

Improved mesenchymal stem cell culture method and culture medium used by same

The invention provides an improved mesenchymal stem cell culture method and a culture medium used by the improved mesenchymal stem cell culture method, and belongs to the technical field of cell culture. The invention provides an improved mesenchymal stem cell culture medium. Comprising the following exogenous additive components: recombinant human serum albumin, recombinant transferrin, a recombinant human epidermal growth factor, a basic fibroblast growth factor, a platelet-derived growth factor, insulin, L-glutamine, reduced glutathione, beta-mercaptoethanol, sodium selenite, mycillin, allicin, heparin and a proliferation promoting agent. The proliferation promoting agent comprises paeoniflorin, panax notoginseng saponins, lycium barbarum polysaccharide and a snow lotus herb alcohol extract. When the culture medium is used for culturing the mesenchymal stem cells, the cell viability and multiplication capacity of the mesenchymal stem cells can be remarkably improved, the cell viability is improved by 50% or above, the cell multiplication capacity is improved by 40% or above, and the culture medium has great application potential in the aspect of culture of the mesenchymal stem cells.
Owner:广东壹加再生医学研究院有限公司

Application of umbilical cord mesenchymal stem cell exosome in preparation of medicine for treating male infertility caused by hidden testis

PendingCN120549976ACell dissociation methodsSkeletal/connective tissue cellsSeminiferous tubuleMouse Testicle
The invention relates to the technical field of biological medicines, in particular to an umbilical cord mesenchymal stem cell exosome and application of the umbilical cord mesenchymal stem cell exosome in preparation of a medicine for treating male infertility caused by hidden testis. The prepared high-concentration umbilical cord mesenchymal stem cell exosome suspension preparation is directly used for treating cultured spermatogonial cells and spermatoblasts in vitro, is injected into the testis of a mouse, and is used for improving the seminiferous tubule and spermatogenic microenvironment of testis tissue and promoting division and proliferation of the spermatogonial cells and the spermatoblasts. The method can effectively reverse oligospermia and azoospermia caused by the hidden testis, and compared with a model without intervention of treatment means, the method can effectively promote increase and even regeneration of sperms in the testis.
Owner:FUJIAN MATERNAL & CHILD HEALTH HOSPITAL

Preparation method of anti-aging cosmetic containing exosome

The invention discloses a preparation method of an anti-aging cosmetic containing exosome, and relates to the technical field of cosmetic preparation, the cosmetic is prepared from the following components in percentage by mass: 1.01%-5.05% of exosome wrapped by liposome, 0.5%-3% of an antioxidant, 1%-3% of a centella asiatica extract, 1%-3% of a rhodiola rosea extract, 10%-15% of a humectant and the balance of a basic matrix; wherein the exosome wrapped by the liposome is a mixture formed by mixing an exosome secreted by adipose-derived mesenchymal stem cells and an exosome secreted by plant cells according to a mass ratio of 1.5: 1.2; the plant is ginseng. According to the skin care product, the antioxidant, the centella asiatica extract and the exosome act together to improve the DPPH clearance rate of the skin care product, the skin brightness is improved, the roughness is reduced, and the excellent anti-aging performance is achieved. The lipid exosome-antioxidant-centella asiatica ternary system disclosed by the invention has a multi-target synergistic effect.
Owner:CARSON (JILIN) CELL RESOURCE LIBRARY MANAGEMENT CO LTD

Construction method and application of genetically modified mesenchymal stem cells

The invention discloses a construction method and application of a gene modified mesenchymal stem cell. The construction method comprises the following steps: constructing a recombinant lentivirus carrying PD-L1 and ICAM1 genes; the recombinant lentivirus carrying the PD-L1 gene and the ICAM1 gene is transfected with mesenchymal stem cells, and the mesenchymal stem cells are screened by puromycin, so that an engineered mesenchymal stem cell strain modified by the PD-L1 gene and the ICAM1 gene is obtained; the mesenchymal stem cells provided by the invention are modified by engineering genes of PD-L1 and ICAM1, and are screened by puromycin to obtain a mesenchymal stem cell strain capable of stably and highly expressing the genes of PD-L1 and ICAM1; after the mesenchymal stem cells highly expressing the PD-L1 and ICAM1 genes are intravenously injected into an autoimmune hepatitis animal model, the autoimmune hepatitis symptom can be remarkably relieved, the liver injury degree can be reduced, the expression of inflammatory factors can be regulated, the inflammatory reaction can be inhibited, and the obvious curative effect can be achieved.
Owner:XIAN CHAOYUE STEM CELL TECH CO LTD

Mesenchymal stem cell-containing product, preparation method, quality control method and application of mesenchymal stem cell-containing product in prevention and treatment of digestive system diseases

The invention belongs to the technical field of stem cells, and particularly relates to a product containing mesenchymal stem cells, a preparation method, a quality control method and application in prevention and treatment of digestive system diseases. According to the preparation method, 1-3 complete culture media are provided for culturing the mesenchymal stem cells, and the obtained mesenchymal stem cells are good in subpackage form; cD73, CD90 and CD105 are highly expressed, and CD19, CD34, CD45, CD11b and HLA-DR are not expressed; the cell proliferation capacity is strong, the osteogenesis and adipogenic differentiation capacity is strong, and the medicine is safe and free of toxic and side effects. The prepared mesenchymal stem cells are high in quality, have good performance of secreting HGF, KGF and IGF-1, and can effectively treat digestive system diseases.
Owner:BEIJING BAYLX PHARMACEUTICAL CO LTD

Application of enhanced and optimized mesenchymal stem cell exosome in knee osteoarthritis and muscle cartilage injury

The invention provides application of an enhanced and optimized mesenchymal stem cell exosome in knee osteoarthritis and muscle cartilage injury, and belongs to the technical field of biological medicine. The treatment activity of the umbilical cord mesenchymal stem cell exosome is remarkably improved by combining a composite pretreatment technology with a 3D culture system. Through the synergistic effect of the total flavonoids of rhizoma drynariae and tanshinone IIA, the pathological process of knee osteoarthritis can be regulated and controlled in multiple dimensions, including inflammatory reaction inhibition, cartilage repair promotion and joint function improvement, and the functional limitation of single-component pretreatment is broken through. The invention provides a safe and efficient novel treatment technical strategy for relieving knee osteoarthritis and muscle cartilage injury, and has a wide clinical application prospect.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV +1

Lipid compositions and methods of delivering therapeutic agents

The purpose of the present invention is to provide a lipid composition capable of delivering a nucleic acid such as RNA to a hematopoietic stem / progenitor cell or a mesenchymal stem cell, and a method for delivering a therapeutic agent to a cell using the lipid composition. The present invention provides a lipid composition comprising (A) a therapeutic agent and (B) a lipid nanoparticle conjugated to a targeting molecule wherein the lipid nanoparticle comprises an ionizable lipid and the targeting molecule specifically binds to a marker of hematopoietic stem / progenitor cells or mesenchymal stem cells.
Owner:FUJIFILM CORP +1

Preparation and application of adipose-derived mesenchymal stem cell exosome with SphK1 inhibition function

The invention relates to preparation and application of an adipose-derived mesenchymal stem cell exosome with an SphK1 inhibition function, and belongs to the technical field of biology. Through a specific preparation method, the adipose-derived mesenchymal stem cell exosome is explored and verified to be a biological product capable of inhibiting liver fibrosis key target gene Sphk1. Compared with other chemically synthesized Sphk1 inhibitors, due to the fact that the Sphk1 inhibitors are derived from ADSC mother cells, the Sphk1 inhibitors not only have biological functions similar to ADSC, such as tissue repair and immune microenvironment regulation, but also have the effect of inhibiting Sphk1 expression, and can be applied to development and application of new drugs for subsequent hepatic fibrosis.
Owner:SHANGHAI SIDEXO BIOTECHNOLOGY CO LTD

Mesenchymal stem cell preparation for promoting knee joint repair, preparation method and application

The invention provides a mesenchymal stem cell preparation for promoting knee joint repair as well as a preparation method and application thereof, and belongs to the technical field of medicines. The preparation method comprises the following steps: loading transforming growth factor-beta1 and interleukin-6 on chitosan microspheres, then preparing a chitosan-oxidized starch-carboxymethyl-beta-cyclodextrin bracket loaded with sustained release microspheres, loading luteolin and quercetin, carrying out mixed culture with mesenchymal stem cells, adding a traditional Chinese medicine extract, and carrying out freeze-drying to obtain the luteolin-quercetin-modified mesenchymal stem cells. The mesenchymal stem cell preparation for promoting knee joint repair is prepared. The preparation method of the carbon anode plate for fluorine preparation is simple, the generation of polarization of the carbon anode plate is prevented, and the carbon anode plate has the advantages of low porosity, low ash content, high mechanical strength, high volume density, obviously prolonged service life, low resistivity and the like, and has a wide application prospect.
Owner:BEIJING SINOMENIUM STEM CELL TECH RES INST CO LTD

SiRNA for reducing IFNGR1 and application thereof

The invention provides siRNA for reducing IFNGR1 and application of the siRNA, and relates to the technical field of biology, the siRNA comprises at least one of IFNGR1-si-1, IFNGR1-si-2 or IFNGR1-si-3, and experiments prove that the knock-down efficiency of the IFNGR1-si-1, the IFNGR1-si-2 and the IFNGR1-si-3 on IFNGR1 genes in mesenchymal stem cells reaches 48% or above. And quantitative expression of the mesenchymal stem cell IFNGR1 can be realized by quantitatively transferring siRNA. A fitting formula is determined by establishing a corresponding relation between the IFNGR1 expression quantity and the total lymphocyte proliferation inhibition rate, and the total lymphocyte proliferation inhibition rate can be calculated by detecting the IFNGR1 expression quantity of the mesenchymal stem cells to be evaluated. Compared with the prior art, the MSC does not need to be evaluated to be co-cultured with the PBMC every time, and a large number of PBMCs are used.
Owner:WUHAN OPTICS VALLEY ZHONGYUAN PHARM CO LTD

Mesenchymal stem cell culture monitoring system based on multiple parameters

The invention provides a mesenchymal stem cell culture monitoring system based on multiple parameters, and relates to the technical field of data processing, and the mesenchymal stem cell culture monitoring system comprises a first-level control instruction generation module which is used for generating a second-level control instruction when the metabolism-morphological abnormality association intensity in a combined fuzzy state matrix is judged to reach a preset association threshold value through a fuzzy rule base; when the abnormal state flag bit indicates that the isolated metabolism is abnormal, a second-level control instruction is generated; the driving unit is used for responding to the first-stage control instruction and cooperatively driving the buffer solution injection unit and the nutrition supplementing pump; responding to the secondary control instruction, and dynamically adjusting the opening degrees of a stirring rate controller, a temperature feedback loop and a gas proportional valve of the bioreactor. The control efficiency and the cell culture stability are improved.
Owner:ALLCARE BIOMEDICAL DEV CO LTD

Umbilical cord mesenchymal stem cell preparation and application thereof in treatment of hepatic diseases

The invention belongs to the technical field of biological medicines, and particularly relates to an umbilical cord mesenchymal stem cell preparation and application thereof to treatment of hepatic diseases. The umbilical cord mesenchymal stem cell preparation comprises umbilical cord mesenchymal stem cells from the third generation to the sixth generation, a GPR55 peptide conjugate and pharmaceutically acceptable auxiliary materials. And the amino acid sequence of the GPR55 peptide conjugate is selected from CKKNSPTLC, CKKNTPTQC or CKKNSPTGC. The umbilical cord mesenchymal stem cell preparation can obviously reduce alpha-SMA and COL-I secreted by hepatic stellate cells and inhibit activation of the hepatic stellate cells, and the fact that the umbilical cord mesenchymal stem cell preparation has anti-hepatic fibrosis activity is further verified in a CCl4 induced hepatic fibrosis model.
Owner:广州飞来爱生命科技有限公司

Cryopreserved dental sac mesenchymal stem cell injection as well as preparation method and application thereof

The invention discloses a cryopreserved dental sac mesenchymal stem cell injection as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. The cryopreserved dental sac mesenchymal stem cell injection comprises a cryopreservation protection solution and human dental sac mesenchymal stem cells MSC with the preservation number of CCTCC NO: C2024384, wherein the cryopreservation protection solution comprises 8 to 12 parts of human serum albumin, 35 to 45 parts of a sodium chloride injection and 45 to 55 parts of a CryoStorCS10 cell cryopreservation solution; the density of the dental sac mesenchymal stem cells is 0.5 * 10 < 7 >-20 * 10 < 7 > cells / mL. The invention further discloses a preparation method of the injection and application of the injection in preparation of drugs for preventing or / and treating periodontal diseases. The injection can be directly used after being unfrozen, can maintain the activity and the biological performance of the dental sac mesenchymal stem cells, enhances the osteogenesis and cartilage formation capabilities of the dental sac mesenchymal stem cells, and has a good effect of treating periodontal diseases.
Owner:成都世联康健生物科技有限公司

Bionic vesicle preparation as well as preparation method and application thereof

The invention belongs to the technical field of bionic nano-drugs, and particularly relates to a bionic vesicle preparation as well as a preparation method and application thereof. The bionic vesicle preparation disclosed by the invention is prepared from the following raw materials: mesenchymal stem cell outer vesicles, nintedanib and DSPE-PEG-HA (hyaluronic acid modified pegylated phospholipid); the nintedanib is loaded in the mesenchymal stem cell outer vesicle, and the DSPE-PEG-HA is coupled to the surface of the mesenchymal stem cell outer vesicle. The bionic vesicle preparation disclosed by the invention can be used for directly delivering a drug to a pulmonary fibrosis injury part through inhalation type drug delivery, and acting on a focus part at a higher local concentration, meanwhile, the exposure of the drug in whole-body circulation is remarkably reduced, the occurrence of side effects is reduced, and the specific targeting intervention and regulation on fibroblasts are realized.
Owner:LUOYANG CENT HOSPITAL